Outcome of autologous platelet concentrate and gas tamponade compared to heavy silicone oil tamponade in persistent macular hole surgery.
Friederike SchaubNasir GözlügölCorinna von GoscinskiPhilip EndersLudwig M HeindlClaudia DahlkePublished in: European journal of ophthalmology (2020)
Re-pars plana vitrectomy combined with autologous platelet concentrate and sulfur hexafluoride 20% seems to achieve at least non-inferior persistent macular hole closure rates and comparable functional results when compared to heavy silicone oil, suggesting autologous platelet concentrate and sulfur hexafluoride 20% as a safe surgical alternative in persistent macular hole. Especially when persistent macular hole closure failed, autologous platelet concentrate with sulfur hexafluoride 20% seems to be superior regarding visual outcome.
Keyphrases
- diabetic retinopathy
- optical coherence tomography
- bone marrow
- perovskite solar cells
- cell therapy
- platelet rich plasma
- cataract surgery
- age related macular degeneration
- solar cells
- minimally invasive
- fatty acid
- stem cells
- coronary artery bypass
- acute coronary syndrome
- room temperature
- surgical site infection
- carbon dioxide
- percutaneous coronary intervention